Desk› Healthcare› Dr. Agarwals Health Care Ltd
Dr. Agarwals Health Care Ltd
Filing rhythm · 30 trading days
17 filings · 4 material · busiest 2026-08-14
What it files
Filings
17 in the window
-
25 August 2026
SASTDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
25 August 2026
Analyst / Investor MeetAnalyst / Investor Meet - Intimation
Intimation of Schedule of Analyst / Investors Meet is submitted.
Company Update / Analyst / Investor Meet View filing →
-
14 August 2026
SASTDisclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for ICICI Prudential Mutual Fund
Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →
-
14 August 2026
SASTDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
14 August 2026
SASTDisclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Invesco Mutual Fund
Insider Trading / SAST / Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 View filing →
-
14 August 2026
SASTDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hyperion Investments Pte Ltd
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
14 August 2026
SASTDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Claymore Investments (Mauritius) Pte Ltd
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
14 August 2026
SASTDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for DB International Trust (Singapore) Ltd
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
7 August 2026
Concall TranscriptEarnings Call Transcript
Transcript of the discussion held on the Unaudited Financial Results (Consolidated & Standalone) of the Company for the quarter ended June 30, 2026, at the analyst call held on August 04, ....
Company Update / Earnings Call Transcript View filing →
-
4 August 2026
Board OutcomeBoard Meeting Outcome for Consolidated And Standalone Unaudited Financial Results For The Quarter Ended June 30, 2026 And Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Outcome of the Meeting of the Board of Directors of the Company held on August 04, 2026, is attached.
Board Meeting / Outcome of Board Meeting View filing →
-
4 August 2026
ResultsConsolidated And Standalone Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2026.
Consolidated and Standalone Unaudited Financial Results of the Company for the quarter ended June 30, 2026 is submitted.
Result / Financial Results View filing →
-
4 August 2026
Investor PresentationInvestor Presentation
Presentation on the Unaudited Financial Results (Consolidated & Standalone) of the Company for the quarter ended June 30, 2026, is attached.
Company Update / Investor Presentation View filing →
-
4 August 2026
Monitoring AgencyMonitoring Agency Report
Dr. Agarwal's Health Care Limited - Monitoring Agency Report for the quarter ended June 30, 2026, is submitted.
Company Update / Monitoring Agency Report View filing →
-
4 August 2026
Analyst / Investor MeetAnalyst / Investor Meet - Outcome
Link for the Audio recording of the Analyst / Earnings Conference call held on the Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter ended June 30, ....
Company Update / Analyst / Investor Meet View filing →
-
28 July 2026
Board MeetingBoard Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended June 30, 2026
Dr. Agarwals Health Care Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 ,inter alia, to consider and approve the Unaudited Financial ....
Board Meeting / Board Meeting View filing →
-
28 July 2026
Analyst / Investor MeetAnalyst / Investor Meet - Intimation
Intimation of Analyst / Earnings Conference call to discuss the Unaudited Financial Results (Standalone & Consolidated) of the Company For The Quarter Ended June 30, 2026, is attached
Company Update / Analyst / Investor Meet View filing →
-
20 July 2026
Newspaper PublicationNewspaper Publication
Newspaper Advertisement of Notice of Hearing of the Company's Petition in relation to the Scheme of Amalgamation between Dr. Agarwal's Eye Hospital Limited and Dr. Agarwal's Health Care ....
Company Update / Newspaper Publication View filing →